-
Name
Ascoric Acid
- EINECS
- CAS No. 36431-82-0
- Density g/cm3
- Solubility
- Melting Point
- Formula C32H42N2O7
- Boiling Point 550.8°Cat760mmHg
- Molecular Weight 0
- Flash Point 224.7°C
- Transport Information
- Appearance
- Safety
- Risk Codes
-
Molecular Structure
- Hazard Symbols
- Synonyms ASCORBIC ACID
- PSA 130.77000
- LogP 3.13390
Ascorbic acid Chemical Properties
Molecular Structure:
Molecular Formula: C32H42N2O7
Molecular Weight: 566.6851
IUPAC Name: (5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanon
Synonyms of Ascorbic acid (CAS NO.36431-82-0): (5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanone ; (5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanone (non-preferred name) ; Calscorbate
Stability: Stable. May be weakly light or air sensitive. Incompatible with oxidizing agents,alkalies, iron, copper
Appearance: white to light yellow crystals or powder
Index of Refraction: 1.711
Density: 1.954 g/ml
Flash Point: 238.2 °C
Boiling Point: 552.7 °C
Melting Point: 191 °C
Classification Code: Drug / Therapeutic Agent
Ascorbic acid Uses
Ascorbic acid (CAS NO.36431-82-0) is used in organic synthesis, drug manufacturing.
Ascorbic acid Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| man | TDLo | intravenous | 2300mg/kg/2D (2300mg/kg) | BLOOD: OXIDANT RELATED (GPD DEFICIENT) ANEMIA | Annals of Internal Medicine. Vol. 82, Pg. 810, 1975. |
| mouse | LD50 | intraperitoneal | 643mg/kg (643mg/kg) | Progress in Mutation Research. Vol. 1, Pg. 682, 1981. | |
| mouse | LD50 | intravenous | 518mg/kg (518mg/kg) | Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 269, 1970. | |
| mouse | LD50 | oral | 3367mg/kg (3367mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, | |
| rat | LD50 | intravenous | > 4gm/kg (4000mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Oyo Yakuri. Pharmacometrics. Vol. 12, Pg. 131, 1976. |
| rat | LD50 | oral | 11900mg/kg (11900mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Oyo Yakuri. Pharmacometrics. Vol. 12, Pg. 131, 1976. |
| rat | LD50 | subcutaneous | > 10gm/kg (10000mg/kg) | Oyo Yakuri. Pharmacometrics. Vol. 12, Pg. 131, 1976. | |
| women | LDLo | intravenous | 900mg/kg (900mg/kg) | KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | Archives of Internal Medicine. Vol. 145, Pg. 950, 1985. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View